Santhosh Palani serves as Executive at Pyxis Oncology, Inc., where they oversee executive responsibilities. Since joining the company, Santhosh Palani has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jun 7, 2024 involved receiving (via award) 6,000 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jun 7, 2024 | PYXS | $0 | Award | 6,000 | $N/A | Discretionary |
Santhosh Palani currently holds 6,000 shares of Pyxis Oncology, Inc. (PYXS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Santhosh Palani has been a net neutral trader of PYXS stock. They have purchased $0 and sold $0 worth of shares.
Santhosh Palani's most recent insider trade was on Jun 7, 2024, when they sold 6,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted